PRONOVA UP LVM is a sodium alginate with a low viscosity (20-200 mPas) that contains at least 50 % mannuronate monomers.
Applications
Applications for Pronova Alginates include, but are not limited to, the encapsulation of therapeutic proteins and living cells for use in cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, foams and scaffolds made of cell tissue, hydrogels, advanced drug delivery and implants, wound care, and medical devices.
Source: Merck
| Product No. |
Product Name |
Product Description |
| 42000101 |
PRONOVA® UP MVG |
medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 % |
| 42000201 |
PRONOVA® UP LVM |
low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 % |
| 4202101 |
PRONOVA® SLG 100 |
sodium alginate solution, Mw 150-250 kDa, guluronate monomer units ≥60 % |
| 42000301 |
PRONOVA® UP MVM |
medium viscosity sodium alginate, viscosity >200 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 % |
| 42000601 |
PRONOVA® UP VLVM |
very low viscosity sodium alginate, viscosity <20 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 % |
| 42000501 |
PRONOVA® UP VLVG |
very low viscosity sodium alginate, viscosity <20 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 % |
| 4202001 |
PRONOVA® SLG 20 |
sodium alginate solution, Mw 75-150 kDa, guluronate monomer units ≥60 % |
| 42000001 |
PRONOVA® UP LVG |
low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 % |